Latest stories on ELDN
Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society
GlobeNewswire56 · neutralproduct/pr
Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society
StockTitan56 · neutralproduct/pr
Eledon files islet cell transplant application, plans Phase 3 kidney trial
The Fly63 · neutralproduct/pr
Eledon Pharmaceuticals GAAP EPS of -$0.27 misses by $0.11
Seeking Alpha34 · bearishearnings
Eledon Pharmaceuticals, Inc. (ELDN) files 8-K
SEC 8-K50 · neutralgeneral
Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire50 · neutralearnings
Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights
StockTitan50 · neutralearnings
Eledon: At The Center Of The Next Medical Frontier
Seeking Alpha73 · bullishproduct/pr
Eledon’s BESTOW Trial Completion: What Tegoprubart Could Mean for Transplant Investing
TipRanks65 · bullishproduct/pr
Eledon Pharmaceuticals stock initiated at Buy by Rodman & Renshaw
Investing.com Analyst Ratings61 · neutralanalyst
Eledon Pharmaceuticals Expands Authorized Shares After Stockholder Vote
TipRanks48 · neutralgeneral
Eledon Pharmaceuticals, Inc. (ELDN) files 8-K
SEC 8-K50 · neutralgeneral
Eledon Pharmaceuticals, Inc. (ELDN) Discusses Updated Long-term Data From Phase 2 BESTOW Clinical Trial in Kidney Transplantation Transcript
Seeking Alpha63 · neutralproduct/pr
Eledon Pharmaceuticals GAAP EPS of -$0.33 misses by $0.12
Seeking Alpha34 · bearishearnings